Correlation Between Ventyx Biosciences and Iteos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Iteos Therapeutics, you can compare the effects of market volatilities on Ventyx Biosciences and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Iteos Therapeutics.

Diversification Opportunities for Ventyx Biosciences and Iteos Therapeutics

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Ventyx and Iteos is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between Ventyx Biosciences and Iteos Therapeutics

Given the investment horizon of 90 days Ventyx Biosciences is expected to generate 2.16 times more return on investment than Iteos Therapeutics. However, Ventyx Biosciences is 2.16 times more volatile than Iteos Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Iteos Therapeutics is currently generating about 0.22 per unit of risk. If you would invest  117.00  in Ventyx Biosciences on May 8, 2025 and sell it today you would earn a total of  133.00  from holding Ventyx Biosciences or generate 113.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Ventyx Biosciences  vs.  Iteos Therapeutics

 Performance 
       Timeline  
Ventyx Biosciences 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Ventyx Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Iteos Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Iteos Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Iteos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Ventyx Biosciences and Iteos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ventyx Biosciences and Iteos Therapeutics

The main advantage of trading using opposite Ventyx Biosciences and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.
The idea behind Ventyx Biosciences and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges